Q4 Interim Report December 31, 2022

Highlights:

• The Group’s sales amounted to 40.7 (29.3) MSEK for the fourth quarter of the year.
• For the full year, sales were 145.9 (96.2) MSEK.
• The Group’s net result totaled -9.8 (-1.3) MSEK for the period October-December, which resulted in a total net result of -10.3 (-12.8) MSEK for the full year.
• EBITDA amounted to 12.8 (4.2) MSEK for the period October-December, and to 16.2 (2.8) MSEK in total for the twelve months of the year.
• Earnings per share were -0.51 (-0.07) SEK for the period October-December, and -0.54 (-0.73) for the four quarters of the year.
• Cash flow before financing activities was -7.8 (-4.7) MSEK for the fourth quarter of the year and -34.0 (-28.6) MSEK for the full year.
• Net liquid assets totaled 21.1 (55.2) MSEK at the end of the period.
• A total number of 528 (401) scalp cooling systems were installed around the world in the first nine months of the year, with the order book containing an additional 217 systems.
• Average Daily Treatment Revenue (ADTR) amounted to 28.54 TUSD (306.09 TSEK) for Q4 2022, corresponding to an increase of 23.5% compared to 23.1 TUSD (204.57 TSEK) for Q4 2021. The figures in SEK have been converted from USD according to the actual exchange rate during each period.
• Recurring income increased from 15.4 MSEK in Q4 2021 to 22.6 MSEK for the same period in
  2022.